Hepatoma-Derived Growth Factor Upregulation Is Correlated With Prognostic Factors of Early-Stage Cervical Adenocarcinoma

International Journal of Molecular Sciences- Switzerland

doi 10.3390/ijms151121492

Full Text

Abstract

Available in

Date

Authors

Publisher

MDPI AG

Related search

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

Expression of Hepatoma-Derived Growth Factor Is Correlated With Lymph Node Metastasis and Prognosis of Gastric Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

Hepatoma‑derived Growth Factor Functions as an Unfavorable Prognostic Marker of Human Gliomas

Oncology Letters
Cancer ResearchOncology
2017English

Hepatoma-Derived Growth Factor Is a Pulmonary Endothelial Cell-Expressed Angiogenic Factor

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2004English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Hepatoma-Derived Growth Factor Stimulates Smooth Muscle Cell Growth and Is Expressed in Vascular Development

Journal of Clinical Investigation
Medicine
2000English

Hepatoma-Derived Growth Factor and Its Role in Keloid Pathogenesis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Hepatoma-Derived Growth Factor-2 Is Highly Expressed During Development and in Spinal Cord Injury

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Clinical Implications of Insulin-Like Growth Factor 1 System in Early-Stage Cervical Cancer

British Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy